BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31044516)

  • 1. Excellent response to bortezomib in a patient with widespread ulcerative pyoderma gangrenosum accompanied by pulmonary involvement and IgA monoclonal gammopathy.
    Bostan E; Günaydın SD; Karaduman A; Evans SE; Elçin G; Gülseren D; Okay M; Çöplü L
    Int Wound J; 2019 Aug; 16(4):1052-1054. PubMed ID: 31044516
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.
    Velasco-Tamariz V; Carreño-Tarragona G; Tous-Romero F; Gil-de la Cruz E; Martín-Clavero E; Rivera-Díaz R
    Int Wound J; 2017 Dec; 14(6):1382-1384. PubMed ID: 28371346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum with pulmonary involvement?
    Liu ZH; Lu XL; Fu MH; Zhang GY; Liu WD
    Eur J Dermatol; 2008; 18(5):583-5. PubMed ID: 18693166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma gangrenosum, acne conglobata, and IgA gammopathy.
    Birnkrant MJ; Papadopoulos AJ; Schwartz RA; Lambert WC
    Int J Dermatol; 2003 Mar; 42(3):213-6. PubMed ID: 12653919
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyoderma gangrenosum associated with subcorneal pustular dermatosis and IgA myeloma.
    Ahmad K; Ramsay B
    Clin Exp Dermatol; 2009 Jan; 34(1):46-8. PubMed ID: 18627386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinaemia.
    Setterfield JF; Shirlaw PJ; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Feb; 144(2):393-6. PubMed ID: 11251581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pyoderma gangrenosum, subcorneal IgA pustulosis and recurrent neutrophilic pleural and pulmonary diseases in a patient with IgA gammopathy].
    Cartier H; Plantin P; Leroy JP; Larzul JJ
    Ann Dermatol Venereol; 1995; 122(3):97-101. PubMed ID: 7486731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma gangrenosum with spleen involvement and monoclonal IgA gammopathy.
    Mijuşković ZP; Zecević RD; Pavlović MD
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):697-9. PubMed ID: 15482299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung involvement in pyoderma gangrenosum: a case report and review of the literature].
    Batalla A; Pérez-Pedrosa A; García-Doval I; González-Barcala FJ; Rosón E; de la Torre C
    Actas Dermosifiliogr; 2011 Jun; 102(5):373-7. PubMed ID: 21397890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexisting pustular and ulcerative pyoderma gangrenosum.
    Nakano S; Oiso N; Kawada A
    Eur J Dermatol; 2012; 22(1):153-4. PubMed ID: 22067845
    [No Abstract]   [Full Text] [Related]  

  • 11. Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy.
    Wayte JA; Rogers S; Powell FC
    Australas J Dermatol; 1995 Feb; 36(1):21-3. PubMed ID: 7763217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapidly progressive renal failure occurring in the course of pyoderma gangrenosum and IgA (lambda) monoclonal gammopathy.
    Akatsuka T; Kawata T; Hashimoto S; Nakamura S; Koike T
    Intern Med; 1997 Jan; 36(1):40-3. PubMed ID: 9058099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum--response to topical nitrogen mustard.
    Tsele E; Yu RC; Chu AC
    Clin Exp Dermatol; 1992 Nov; 17(6):437-40. PubMed ID: 1486712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vegetative pyoderma gangrenosum.
    Kim RH; Lewin J; Hale CS; Meehan SA; Stein J; Ramachandran S
    Dermatol Online J; 2014 Dec; 20(12):. PubMed ID: 25526339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyoderma gangrenosum and monoclonal gammopathy.
    Powell FC; Schroeter AL; Su WP; Perry HO
    Arch Dermatol; 1983 Jun; 119(6):468-72. PubMed ID: 6859886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyoderma gangrenosum with extensive pulmonary involvement.
    Scherlinger M; Guillet S; Doutre MS; Beylot-Barry M; Pham-Ledard A
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):e214-e216. PubMed ID: 27658239
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis].
    Lorincz M; Kleszky M; Szalóki T; Szalóki T
    Orv Hetil; 2010 Jan; 151(4):144-7. PubMed ID: 20071320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal gammopathy in the setting of Pyoderma gangrenosum.
    Saeidi V; Garimella V; Shaji K; Wetter DA; Davis MDP; Todd A; Dutz J; Alavi A
    Arch Dermatol Res; 2024 May; 316(6):268. PubMed ID: 38795175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wound Healing Disorder Caused by Pyoderma Gangrenosum.
    Drerup C; Wefelmeier L; Goerge T
    Am Surg; 2018 Mar; 84(3):e112-e113. PubMed ID: 30454428
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pyoderma gangrenosum vegetans. An overview of chronic pyoderma vegetans and pyoderma gangrenosum].
    Schnetter D; Haneke E
    Hautarzt; 1994 Sep; 45(9):635-8. PubMed ID: 7960772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.